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Abstract
SCF-Skp2 E3 ubiquitin ligase (Skp2 hereafter) targets several cell cycle regulatory proteins for degradation via the ubiquitin-
dependent pathway. However, the target-specific physiological functions of Skp2 have not been fully elucidated in kidney
diseases. We previously reported an increase in Skp2 in progressive nephropathy and amelioration of unilateral ureteral
obstruction (UUO) renal injury associated with renal accumulation of p27 in Skp2
2/2 mice. However, it remains unclear
whether the amelioration of renal injury in Skp2
2/2 mice is solely caused by p27 accumulation, since Skp2 targets several
other proteins. Using Skp2
2/2p27
2/2 mice, we investigated whether Skp2 specifically targets p27 in the progressive
nephropathy mediated by UUO. In contrast to the marked suppression of UUO renal injury in Skp2
2/2 mice, progression of
tubular dilatation associated with tubular epithelial cell proliferation and tubulointerstitial fibrosis with increased expression
of collagen and a-smooth muscle actin were observed in the obstructed kidneys in Skp2
2/2p27
2/2 mice. No significant
increases in other Skp2 target proteins including p57, p130, TOB1, cyclin A and cyclin D1 were noted in the UUO kidney in
Skp2
2/2 mice, while p21, c-Myc, b-Myb and cyclin E were slightly increased. Contrary to the ameliorated UUO renal injure by
Skp2-deficiency, the amelioration was canceled by the additional p27-deficiency in Skp2
2/2p27
2/2 mice. These findings
suggest a pathogenic role of the reduction in p27 targeted by Skp2 in the progression of nephropathy in UUO mice.
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Introduction
Cell proliferation is a basic biological mechanism that is
controlled by a network of proteins including cyclins, cyclin-
dependent kinases (CDKs) [1] and cyclin-dependent kinase
inhibitors (CKIs) [2]. The CKI p27
Kip1 (p27), a known negative
regulator of the cell cycle, is abundantly expressed in most normal
quiescent cells, and its level declines when cells are stimulated to
proliferate in response to mitotic stimuli [3,4]. In vitro studies have
shown that experimentally reducing the level of p27 protein
augments the proliferative response to mitogens [5,6], while forced
overexpression of p27 inhibits cell proliferation [4]. The level of
p27 protein is controlled not only by transcriptional activation but
also by proteolytic degradation of p27 protein via the ubiquitin-
proteasome system as a post-translational regulation. Consequent-
ly, G1-cyclin-CDK complexes become activated to phosphorylate
retinoblastoma protein and advance the cell cycle from G1 to S
phase [7,8].
The ubiquitin-proteasome pathway of protein degradation plays
an important role in controlling the abundance of cell cycle
regulatory proteins [9,10]. The rapidity and substrate specificity of
protein degradation through the ubiquitin-proteasome pathway
are consistent with its role in controlling the fluctuations in the
intracellular concentrations of cyclins and CKIs. Skp2 is known to
be the F-box protein component of an SCF-type ubiquitin ligase
that interacts with p27, and the SCF-Skp2 complex promotes p27
degradation by ubiquitination [11,12]. Skp2
2/2 mice have been
reported to show cellular accumulation of p27 [13]. Moreover, cdc
kinase subunit 1 (Cks1) is required for degradation of p27
mediated by Skp2 [14]. It has also been reported that Skp2 targets
several cell cycle regulatory proteins including p27, p21, p57,
cyclin E, cyclin A and cyclin D1 for degradation via the ubiquitin-
dependent pathway [15]. However, it remains unclear which
proteins are targeted by Skp2 for degradation in specific biological
processes or diseases.
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e36249In the kidney, cell proliferation is supposed to be a pivotal
response to damage, and culminates in the development of renal
injury and fibrosis. Proliferation of tubular cells is a characteristic
feature of obstructed kidneys in unilateral ureteral obstruction
(UUO). UUO is a representative model of progressive tubuloin-
terstitial injury that is suitable for investigating the cellular and
molecular events that occur during the progression of renal fibrosis
associated with cell proliferation and apoptosis [16,17]. An
imbalance between cell proliferation and apoptosis has been
shown to lead to unchecked apoptosis, resulting in progressive cell
loss, renal tubular atrophy and interstitial fibrosis [18].
It has been reported that both the mRNA and protein levels of
the CDKIs p27 and p21 are upregulated at an early stage in the
obstructed kidneys of UUO mice [19–21]. Marked increases in
renal tubular epithelial cell proliferation and apoptosis are also
observed in the obstructed kidneys in p27
2/2 mice [22]. Since
upregulation of p27 safeguards against excessive renal epithelial
cell proliferation, p27 may be involved in protecting cells and
tissues against inflammatory injury. On the other hand, no
significant changes in tubular epithelial cell proliferation and
apoptosis are found in the obstructed kidneys in p21
2/2 mice,
despite the proliferation of interstitial cells, especially myofibro-
blasts [23]. Unlike p27, p21 limits the magnitude of early
myofibroblast proliferation, but does not seem to be essential for
the regulation of tubular epithelial cell proliferation and apoptosis
following UUO [23]. These studies suggest differential regulatory
roles for the CDKIs p27 and p21 in UUO kidneys.
Recently, we reported that Skp2 mRNA was increased in UUO
kidneys and that the progression of fibrotic tubulointerstitial
damage in UUO kidneys was attenuated in Skp2
2/2 mice [24].
Although the p27 protein level was increased in the obstructed
kidneys in wild-type (WT) mice, it was significantly higher in
Skp2
2/2 mice. p27 accumulation, which results from SCF-Skp2
ubiquitin ligase deficiency in Skp2
2/2 mice, inhibited the renal
tubular epithelial cell proliferation, and was involved to the
amelioration of the renal damage induced by obstructive
nephropathy. Moreover, we found upregulation of not only
Skp2, but also Cks1, an essential cofactor for the SCF-Skp2
ubiquitin ligase in targeting p27, which were induced by activation
of the TNF-a/NF-kB pathway in two models of chronic
progressive nephropathy, namely UUO mice and chronic anti-
thymocyte serum nephropathy rats [25]. However, because Skp2
has multiple targets including p21, p57, c-Myc, p130 and TOB1 in
addition to p27 [26–30], little is known about the specific target of
Skp2 in renal lesions.
In the present study, we investigated whether degradation of
p27 targeted by Skp2 is required for the development of
tubulointerstitial injury in UUO kidneys by comparing WT,
Skp2
2/2 and p27
2/2 mice with Skp2
2/2p27
2/2 mice. Contrary
to the amelioration of UUO renal injury by Skp2-deficiency, the
amelioration was abolished by the additional deficiency of p27 in
Skp2
2/2p27
2/2 double knockout mice. These findings suggest
that p27 is the key molecule targeted by Skp2 that is involved in
the progression of renal injury in UUO mice.
Results
Levels of Skp2 target proteins in the UUO kidney
First, we investigated the levels of Skp2 target proteins in UUO
renal injury in WT and Skp2
2/2 mice. Consistent with our
previous report [24], accumulation of p27 and p21 was observed
in the UUO kidneys in Skp2
2/2 mice (Figure 1). The levels of c-
Myc, b-Myb and cyclin E were also slightly increased, whereas
p57, p130, TOB1, cyclin A and cyclin D1 did not accumulate, in
the UUO kidneys in Skp2
2/2 mice. These findings suggest that
the increased Skp2 promoted the degradation of p27, p21, c-Myc,
b-Myb and cyclin E in the UUO kidneys. However, it remains
unclear which protein degradation targeted by Skp2 plays an
important role in the progression of the obstructive nephropathy.
To address this question, we first focused on p27 and compared its
levels in UUO renal injury in Skp2
2/2p27
2/2 double-knockout
mice with those in WT, Skp2
2/2 and p27
2/2 mice.
Genotypes of Skp2
2/2, Skp2
2/2p27
2/2 and p27
2/2 mice
The genotypes of the Skp2
2/2, Skp2
2/2p27
2/2 and p27
2/2
mice were confirmed by PCR (Figure S1A). p27 level was
increased in Skp2
2/2 mice comparing with wild-type mice after
UUO operation, whereas p27 protein was not detected in both
p27
2/2 and Skp2
2/2p27
2/2 mice (Figure S1B).
Diminished ameliorative effect of Skp2-deficiency on the
obstructive renal injury in Skp2
2/2p27
2/2 mice
In accordance with our previous report [24], remarkable
amelioration of the tubulointerstitial fibrosis and significant
decreases in the numbers of dilated tubules, tubular cells and
interstitial cells were noted in the UUO kidneys in Skp2
2/2 mice
compared with WT mice. In contrast, the amelioration of the
UUO renal injury noted in Skp2
2/2 mice was almost completely
abolished, and instead rather aggravated, by the additional p27-
deficiency in Skp2
2/2p27
2/2 mice (Figure 2, A–E). Aggravation
of the UUO renal injury was also observed in p27
2/2 mice. There
were no significant renal histological changes in the non-
obstructed CLK kidneys in all genotypes of mice.
Diminished suppressive effect of Skp2-deficiency on
tubular epithelial cell proliferation and apoptosis in UUO
kidneys in Skp2
2/2p27
2/2 mice
The number of Ki67-positive proliferative tubular epithelial
cells per tubule was significantly increased in the UUO kidneys in
WT mice, but was suppressed in Skp2
2/2 mice. However, the
suppression of tubular epithelial cell proliferation noted in the
UUO kidneys in Skp2
2/2 mice was diminished in Skp2
2/2
p27
2/2 mice (Figure 3, A–F). A marked increase in proliferative
tubular cells was observed in p27
2/2 mice. The number of Ki67-
positive interstitial cells was also increased in the UUO kidneys in
WT mice compared with the CLK kidneys, and was slightly
Figure 1. Immunoblot analyses of the previously reported
Skp2 target proteins in UUO kidneys. The levels of the previously
reported Skp2 target proteins were detected by western blot analysis in
the obstructed kidneys in WT (Skp2
+/+) and Skp2
2/2 mice at 7 days after
UUO. a-tubulin was evaluated as an internal control.
doi:10.1371/journal.pone.0036249.g001
Renal Damage in Skp2
2/2 p27
2/2 Mice
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2/2 mice (Figure 3, A–E
and G). On the other hand, marked increases in Ki67-positive
proliferative interstitial cells were observed in the UUO kidneys in
Skp2
2/2p27
2/2 and p27
2/2 mice.
Compared with the CLK kidneys in WT mice, the numbers of
TUNEL-positive apoptotic tubular and interstitial cells were
increased in the UUO kidneys in WT mice, but were significantly
fewer in Skp2
2/2 mice. In contrast, the suppression of TUNEL-
positive apoptotic tubular and interstitial cells in the UUO kidneys
noted in Skp2
2/2 mice was diminished by the additional p27-
deficiency in Skp2
2/2p27
2/2 mice (Figure 4, A–G). The
increases in the numbers of TUNEL-positive apoptotic tubular
and interstitial cells were also observed in the UUO kidneys in
p27
2/2 mice.
Figure 2. Levels of UUO renal injury. (A) Representative microscopic images of CLK and UUO kidneys in WT, Skp2
2/2, Skp2
2/2p27
2/2 and
p27
2/2 mice (Masson’s trichrome staining; scale bars: 50 mm). Increases in the interstitial area, tubular dilatation and atrophy, and interstitial cell
infiltration are observed in the UUO kidneys in WT mice. However, the severities of these lesions are markedly less in the UUO kidneys in Skp2
2/2
mice. In contrast, aggravation of the UUO renal injury is noted in Skp2
2/2p27
2/2 and p27
2/2 mice. (B) The severity of fibrotic tubulointerstitial
lesions was graded semiquantitatively as follows: 0, absent (0%); 1, weak (#10%); 2, mild (.10 to #30%); 3, moderate (.30 to #50%); 4, strong
(.50%) in WT, Skp2
2/2, Skp2
2/2p27
2/2 and p27
2/2 mice at 7 days after UUO. (C–E) The numbers of dilated tubules (C), renal tubular epithelial cells
in a tubule (D), and tubular interstitial cells (E) were counted and evaluated statistically in the UUO kidneys in WT, Skp2
2/2, Skp2
2/2p27
2/2 and
p27
2/2 mice at 7 days after UUO. The CLK kidneys in WT mice were evaluated as controls. *P,0.05, **P,0.01 versus WT CLK kidneys,
#P,0.05,
##P,0.01 versus WT UUO kidneys and
{P,0.05,
{{P,0.01 versus Skp2
2/2 UUO kidneys.
doi:10.1371/journal.pone.0036249.g002
Renal Damage in Skp2
2/2 p27
2/2 Mice
PLoS ONE | www.plosone.org 3 April 2012 | Volume 7 | Issue 4 | e36249Diminished suppressive effect of Skp2-deficiency on
progression of tubulointerstitial fibrosis in UUO kidneys
in Skp2
2/2p27
2/2 mice
Comparing with the CLK kidneys in WT mice, type I collagen-
positive interstitial area was significantly increased in the UUO
kidneys in WT mice, but the increment was significantly
suppressed in Skp2
2/2 mice. On the other hand, the suppression
was markedly diminished by the additional p27-deficiency in the
UUO kidneys in Skp2
2/2p27
2/2 mice (Figure 5B). Similarly, the
interstitial areas positive for a-SMA and F4/80 were markedly
increased in the UUO kidneys in WT mice. Although these
increments were significantly suppressed in Skp2
2/2 mice, the
suppression was almost completely abolished by the additional
p27-deficiency in Skp2
2/2p27
2/2 mice (Figure 5, A, C and D).
Increases in type I collagen-positive fibrotic interstitial area, a-
SMA and interstitial migration of F4/80-positive macrophages
were also observed in the UUO kidneys in p27
2/2 mice. In
addition, we performed QRT-PCR to measure the mRNA
expression levels of COL I, a-SMA, F4/80 and fibronectin. As
shown in Figure S2, comparing with the CLK kidneys in WT
mice, mRNA expression levels of type I collagen, a-SMA, F4/80
and fibronectin were increased in the UUO kidneys in WT mice,
but the increments were suppressed in Skp2
2/2 mice. On the
other hand, the suppression was diminished by the additional p27-
deficiency in the UUO kidneys in Skp2
2/2p27
2/2 mice (Figure
S2). These tendencies were consistent with immunohistochemical
data in Figure 5A. We also found that vimentin-positive interstitial
Figure 3. Numbers of Ki67-positive proliferative tubular epithelial and interstitial cells in UUO kidneys. (A–E) Sections of CLK kidneys
in WT mice (A) and UUO kidneys in WT (B), Skp2
2/2 (C), Skp2
2/2p27
2/2 (D) and p27
2/2 (E) mice were subjected to immunostaining with an anti-
Ki67 antibody, scale bars: 50 mm( F, G) The numbers of Ki67-positive tubular epithelial cells (F) and Ki67-positive interstitial cells (G) in the UUO
kidneys were counted in the mice of each genotype. The CLK kidneys in WT mice were evaluated as controls. *P,0.05, **P,0.01 versus WT CLK
kidneys,
#P,0.05 versus WT UUO kidneys and
{P,0.05,
{{P,0.01 versus Skp2
2/2 UUO kidneys.
doi:10.1371/journal.pone.0036249.g003
Renal Damage in Skp2
2/2 p27
2/2 Mice
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but the increment was suppressed in Skp2
2/2 mice (Figure S3).
On the other hand, the suppression was markedly diminished by
the additional p27-deficiency in the UUO kidneys in Skp2
2/
2p27
2/2 mice. These results strongly suggested that the Skp2/
p27 pathway may contribute to EMT in progressive UUO renal
injury.
Discussion
SCF-Skp2 is an important E3 ligase that targets several cell
cycle regulatory proteins. However, it has not been fully elucidated
which protein degradation targeted by Skp2 contributes to the
physiological and pathological events in progressive renal injury.
In Skp2
2/2 mice, we previously reported that accumulation of
p27, which had escaped from Skp2-mediated ubiquitin-proteaso-
mal degradation, resulted in the suppression of tubular epithelial
cell proliferation, tubular dilatations and tubulointerstitial fibrosis
in UUO renal injury [24]. In the present study, we compared the
UUO renal injury among WT, Skp2
2/2, Skp2
2/2p27
2/2 and
p27
2/2 mice, and found that 1) the UUO renal injury was less
severe in Skp2
2/2 mice, in which renal accumulation of p27 was
noted, 2) the amelioration of UUO renal injury noted in Skp2
2/2
mice, was almost completely abolished, and instead rather
Figure 4. Numbers of TUNEL-positive apoptotic tubular epithelial and interstitial cells in UUO kidneys. (A–E) Sections from CLK kidneys
in WT mice (A) and UUO kidneys in WT (B), Skp2
2/2 (C), Skp2
2/2p27
2/2 (D) and p27
2/2 (E) mice were subjected to TUNEL staining, scale bars:
50 mm. (F, G) The numbers of TUNEL-positive tubular epithelial cells (F) and TUNEL-positive interstitial cells (G) in the UUO kidneys were counted in
the mice of each genotype. The CLK kidneys in WT mice were evaluated as controls. *P,0.05, **P,0.01 versus WT CLK kidneys,
#P,0.05,
##P,0.01
versus WT UUO kidneys and
{P,0.01 versus Skp2
2/2 UUO kidneys.
doi:10.1371/journal.pone.0036249.g004
Renal Damage in Skp2
2/2 p27
2/2 Mice
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2/2p27
2/2
double-knockout mice, and 3) the aggravation of UUO renal
injury was also noted in p27
2/2 mice. These findings suggest that
the decrease in p27 targeted by Skp2 is involved in the progression
of UUO renal injury.
No significant renal accumulation of p57, p130, TOB1, cyclin A
or cyclin D1, which are also Skp2 targets, was observed, suggesting
that these proteins are not targets for Skp2 in UUO renal injury.
In contrast, increases in several other possible Skp2 targets,
including p21, c-Myc, b-Myb and cyclin E, were also observed in
the ameliorated UUO kidneys in Skp2
2/2 mice, but showed slight
increments compared with p27 accumulation. Because c-Myc, b-
Myb and cyclin E accelerate the cell cycle and stimulate cell
proliferation, it is unlikely that their increases are involved in the
suppression of tubular and interstitial cell proliferation in UUO
renal injury in Skp2
2/2 mice. However, the role of the moderately
increased p21, another CDKI possibly targeted by Skp2, in the
suppression of UUO renal injury in Skp2
2/2 mice remains to be
clarified. Since it has been reported that p21 regulates interstitial
cells in UUO kidneys [23], the decrease in p21 targeted by Skp2
may be involved in the progression of interstitial cell proliferation
in UUO kidneys. Further studies using Skp2
2/2p21
2/2 double-
Figure 5. Levels of tubulointerstitial fibrotic lesions. (A) Representative images of UUO kidney sections in WT, Skp2
2/2, Skp2
2/2p27
2/2 and
p27
2/2 mice immunostained for type I collagen (top panels), a-SMA (middle panels) and F4/80 (bottom panels) at 7 days after UUO, scale bars:
50 mm. (B) The ratios of the interstitial area in the UUO kidneys were quantified using the sections stained for type I collagen. (C, D) The intensities of
the a-SMA (C) and F4/80 (D) immunostaining were quantified using Scion Image software. The CLK kidneys in WT mice were evaluated as controls.
*P,0.01 versus WT CLK kidneys,
#P,0.01 versus WT UUO kidneys and
{P,0.05,
{{P,0.01 versus Skp2
2/2 UUO kidneys.
doi:10.1371/journal.pone.0036249.g005
Renal Damage in Skp2
2/2 p27
2/2 Mice
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injury.
p27 deletion not only abolished the protective effects of
Skp2
2/2 genotype, but also makes the renal lesion worse
compared to the wild type. p27 deletion may promote unsched-
uled activations of various cyclin-dependent kinases. Thereby
renal epithelial cell growth and following tubular dilation induced
by renal obstruction may be irregularly enhanced in p27
2/2 mice.
In the Skp2
2/2 (Figure 1) and Skp2
2/2p27
2/2 mice (data not
shown), another Skp2 targets such as p21 and c-Myc are
accumulated. c-Myc plays roles for promotion of cell growth
and apoptosis, whereas p27 and p21 are negative regulators in cell
proliferation. The increased c-Myc may play opposite roles against
p27 and p21 for tubular epithelial cell proliferation. Moreover, it
has been reported that p21 inhibits c-Myc expression [31]. c-Myc
promotes Skp2-mediated degradation of p27 [32]. Therefore,
Skp2 target cell cycle regulators are functionally related each
other. Skp2 deletion may induce these unbalances of cell cycle
regulators not only directly but also indirectly, thereby the cell
proliferation and apoptosis were abrogated in the UUO kidney.
In addition to the diminished amelioration of tubular and
interstitial cell proliferation, aggravation of interstitial fibrosis
composed of increased deposition of type I collagen, interstitial
expression of a-SMA, and infiltration of macrophages was noted
in the UUO kidneys in Skp2
2/2p27
2/2 and p27
2/2 mice. These
findings suggest that the regulation of p27 by Skp2 is involved in
the development of tubulointerstitial fibrosis. It has been reported
that type II epithelial-mesenchymal transdifferentiation (EMT)
occurs in progressive nephropathies to differentiate myofibroblasts
from renal epithelial cells [33]. The expression levels of a-SMA,
fibronectin and vimentin are closely associated with type II EMT
as typical markers for myofibroblasts [33–36]. Our data suggest
that the Skp2/p27 pathway may contribute to EMT in progressive
UUO renal injury, although further studies are required.
Talking all our findings into consideration, it is suggested that
degradation of p27 targeted by Skp2 accelerated the progression of
renal tubular epithelial cell proliferation, tubular dilation and
tubulointerstitial fibrosis in UUO renal injury. Therefore, we
conclude that p27 is a main target for Skp2 and that degradation
of p27 by Skp2 is required for the progression of renal injury
mediated by UUO. Based on this, inhibitors of SCF-Skp2/Cks1
E3 ligase that specifically promote p27 degradation may be
effective for the treatment of progressive nephropathy. Further
studies are required to examine this possibility.
Methods
Experimental animals
The generation of Skp2
2/2 mice [13] and p27
2/2 mice [37]
were signed by Nakayama et al. To obtain WT [Skp2
+/+p27
+/+],
Skp2
2/2, Skp2
2/2p27
2/2 and p27
2/2 offspring, heterozygous
Skp2
+/2p27
+/2 mice were mated. The mice included in this study
were 6-week-old male mice weighing 20–25 g. The mice were
allowed free access to food and water, and were maintained under
a 12-h/12-h light-dark cycle. We confirmed the WT and disrupted
alleles of Skp2 and p27 by PCR. The mice were treated according
to protocols approved by the Hamamatsu University School of
Medicine Animal Care Committees at the Center Animal Care
facility.
Experimental design
Ureteral obstruction was achieved by ligating the left ureter with
3-0 silk through a left lateral incision. WT, Skp2
2/2,
Skp2
2/2p27
2/2 and p27
2/2 mice (n=4–5 per group) were
sacrificed at 7 days after the operation. The obstructed (UUO) and
non-obstructed contralateral (CLK) kidneys were harvested from
each mouse and subjected to the analyses described below. The
experimental protocol was approved by the Ethics Review
Committee for Animal Experimentation of Hamamatsu Univer-
sity School of Medicine.
Immunoblot analysis
Whole kidney tissues were dissolved in RIPA buffer (25 mmol/
L Tris-HCl pH 7.4, 150 mmol/L NaCl, 0.1% SDS, 0.5% Triton-
X100, 0.5% sodium deoxycholate) containing protease inhibitors
(150 mg/ml PMSF, 5 mg/ml aprotinin, 5 mg/ml pepstatin,
5 mg/ml leupeptin, 5 mg/ml E-64) at 4uC. After incubation for
30 min, the lysates were centrifuged at 130006g for 15 min at
4uC. The protein concentrations of the lysates were measured
using a protein assay reagent (Bio-Rad Laboratories, Hercules,
CA). Soluble lysates were boiled with 46SDS sample buffer
(250 mmol/L Tris-HCl pH 6.8, 12% SDS, 40% glycerol, 20% 2-
mercaptoethanol, 1% bromophenol blue) for 8 min. Equal
amounts of proteins were loaded and separated by SDS-PAGE.
The separated proteins were transferred to polyvinylidene
difluoride membranes, followed by immunoblotting with the
following antibodies: mouse monoclonal anti-p27 and anti-p130
(BD Transduction Laboratories, San Jose, CA); anti-p21 (Santa
Cruz Biotechnology, Santa Cruz, CA); anti-Myc (Cell Signaling
Technology, Danvers, MA); anti-a-tubulin (Sigma, St. Louis,
MO); rabbit monoclonal anti-p57 (Abcam, Cambridge, UK);
rabbit polyclonal anti-TOB (Abcam); anti-b-Myb, anti-cyclin A,
anti-cyclin D1 and anti-cyclin E (Santa Cruz Biotechnology). a-
tubulin was evaluated as an internal control. The antibody-bound
proteins were visualized using an enhanced chemiluminescence
system (Perkin Elmer, Wellesley, MA).
Histopathological and immunohistochemical analyses
Kidney tissues were fixed in 4% paraformaldehyde in PBS and
embedded in paraffin. Tissue sections (3-mm thickness) were
rehydrated and subjected to Masson’s trichrome staining for
histopathological analysis. The levels of fibrotic tubulointerstitial
lesions were graded semiquantitatively as follows: 0, absent (0%);
1, weak (#10%); 2, mild (.10 to #30%); 3, moderate (.30 to
#50%); 4, strong (.50%) in twenty randomly selected non-
overlapping renal cortical fields at 6400 magnification. The
percentage of dilated tubules per total tubules, the number of renal
tubular epithelial cells in a tubule which was obtained as the
number of tubular epithelial cells divided by the number of
tubules, and the number of interstitial cells were counted in 10
randomly selected non-overlapping renal cortical fields at 6400
magnification. The immunoreactivities for Ki67, type I collagen,
a-smooth muscle actin (a-SMA) and F4/80, a marker protein for
macrophages, were determined using a Histofine SAB-PO kit
(Nichirei, Tokyo, Japan) as a standard biotin-streptavidin-perox-
idase method as described previously [24]. The primary antibodies
were as follows: rabbit polyclonal anti-human Ki67 (Novocastra
Laboratories, Newcastle-upon-Tyne, UK); anti-mouse type I
collagen (Abcam); mouse monoclonal anti-human a-SMA
(DAKO, Hamburg, Germany); and rat anti-mouse F4/80
(Serotec, Oxford, UK). The secondary antibodies were affinity-
purified biotinylated goat anti-mouse or anti-rabbit immunoglob-
ulin, and peroxidase-conjugated anti-rat immunoglobulin (Ni-
chirei, Tokyo, Japan). The kidney sections were lightly counter-
stained with hematoxylin. The numbers of Ki67-positive tubular
epithelial and interstitial cells were counted in 10 randomly
selected non-overlapping renal cortical fields at 6400 magnifica-
tion and the mean values were obtained. The type I collagen-
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PLoS ONE | www.plosone.org 7 April 2012 | Volume 7 | Issue 4 | e36249positive interstitial area and the areas positive for a-SMA and F4/
80 were quantified in 10 randomly selected non-overlapping fields
at 6400 magnification using Scion Image software (Scion Corp.,
Frederick, MD). We set a threshold to automatically compute the
positive areas for each stain and computed the ratio of the positive
areas to the whole interstitial area.
Evaluation of apoptosis
Deoxynucleotidyl transferase-mediated dUTP nick end labeling
(TUNEL) was performed to detect apoptotic cell death using an
ApopTag Plus Peroxidase In Situ Apoptosis Detection Kit
(Chemicon, Temecula, CA). For each kidney, the number of
apoptotic tubular epithelial and interstitial cells in 10 non-
overlapping renal cortical fields was counted under 6400
magnification. The number of TUNEL-positive nuclei was
averaged for each field.
Statistical analysis
Statistical analysis was performed using computer-assisted
software (StatView 5.0; SAS Institute Inc.). All values are given
as means 6 SEM. Differences between groups were examined for
statistical significance by analysis of variance. When a significant
difference was found between two groups, a further statistical
analysis was performed using the Bonferroni–Dunn test. Values of
P,0.05 were considered to indicate statistical significance.
Supporting Information
Figure S1 The expression of Skp2 and/or p27 in WT,
Skp2
2/2, Skp2
2/2p27
2/2 and p27
2/2 mice. The geno-
types of the WT, Skp2
2/2, Skp2
2/2p27
2/2 and p27
2/2 mice
were confirmed by PCR (A). The PCR primer sequences of Skp2
were sense 59-CAGACCCTGACGCACCTCACG-39 and anti-
sense 59-TTCTGACGCCCCGTTGCCTGCT-39for WT, 59-
GGTGGATGTGGAATGTGTGCGAGGC-39 for knockout al-
lele; and of p27 were sense 59-CGTGGGGTGTAGAA-
TACTCCTTGT-39 and antisense 59-GATACGACCGTCCC-
TATCCTTTG-39 for WT, 59-TGCTAAAGCGCATGCTCC-
AGACTG-39 for KO. Primers for glyceraldehyde-3-phosphate
dehydrogenase (GAPDH), used as an internal control, were sense
59-TGCACCACCAACTGCTTAG-39 and antisense 59-GATG-
CAGGGATGATGTTC-39. The protein level of p27 in CLK (C)
and UUO (U) kidneys in each genotype mouse (B). a-tubulin was
used an internal control.
(TIF)
Figure S2 mRNA expression of UUO renal injury.
mRNA level of COL I (A), a-SMA (B), F4/80 (C) and Fibronectin
(D) measured by quantitative RT-PCR from CLK in WT mouse,
and UUO kidneys in WT, Skp2
2/2, Skp2
2/2p27
2/2 and
p27
2/2 mice. Total RNA was extracted from whole kidney tissue
using the Isogen (Wako, Osaka, Japan) according to the
manufacturer’s instructions. Reverse transcription of the RNA
was performed using the SuperScript First-Strand Synthsis System
for RT-PCR kit (Invitrogen, Carlsbad, CA) with 2.5 mg of total
RNA. The resulting cDNA was subjected to real-time PCR using
the Roter-Gene 3000 System (Corbett Research, Mortlake,
Australia) for amplification and online quantification. All PCR
experiments were performed using a QuantiTect SYBRGreen PCR
kit purchased from TAKARA (TAKARA, Shiga, Japan). The PCR-
primer sequences for COL I were sense 59-AGAGCATGACC-
GATGGATTCC-39 and antisense 59-TTGCCAGTCTGCT-
GGTCCATG-39 for a-SMA were sense 59- ACTGGGACGA-
CATGGAAAAG-39 and antisense 59-CATCTCCAGAGTCCAG-
CACA-39: for F4/80 were sense 59-GATGGGGGATGACCA-
CACTT -39 and antisense 59-TTCAGGGCAAACGTCTCG-39:
forFibronectinweresense59-ACGGTTTCCCATTACGCCAT-39
and antisense59-CTTTCCATTCCCGAGGCAT-39.GA PD Hw as
evaluatedasaninternalcontrol.TheamountofCOLI,a-SMA,F4/
80 and Fibronectin mRNA was normalized for GAPDH mRNA in
each sample. The CLK kidneys in WT mice were evaluated as
controls.
*P,0.05,
**P,0.005 versus WT CLK kidneys,
#P,0.05
versus WT UUO and
{P,0.05 versus Skp2
2/2 UUO.
(TIF)
Figure S3 The immunoreactivity for Vimentin in UUO
kidneys. Representitive images of immunohistochemical staining
for Vimentin from WT CLK and UUO kidneys in each genotype
mouse. The primary antibody was rabbit polyclonal anti-human
Vimentin (Santa Cruz), scale bars: 50 mm.
(TIF)
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